<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Gastro-duodenal content reflux from <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-esophageal reflux disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>) induces the <z:mp ids='MP_0001845'>inflammation</z:mp>-<z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0009308'>adenocarcinoma</z:mp> sequence </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="49200">Proton pump inhibitors</z:chebi> (<z:chebi fb="4" ids="53266">PPIs</z:chebi>) are potent blockers of gastric acid secretion, which are widely used for treating <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> and <z:hpo ids='HP_0004398'>peptic ulcer</z:hpo>-associated acid-secreting diseases </plain></SENT>
<SENT sid="2" pm="."><plain>The effect of <z:chebi fb="4" ids="53266">PPI</z:chebi> therapy on esophageal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> remains unclear </plain></SENT>
<SENT sid="3" pm="."><plain>While some studies suggest <z:chebi fb="4" ids="53266">PPIs</z:chebi> result in a significant reduction in the risk of developing <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, others suggest that <z:chebi fb="4" ids="53266">PPIs</z:chebi> have no effect </plain></SENT>
<SENT sid="4" pm="."><plain>Recent studies have revealed that <z:chebi fb="4" ids="53266">PPIs</z:chebi> can exert anti-inflammatory effects such as anti-oxidant properties and immunomodulatory effects through their interactions with neutrophils, monocytes, endothelial and epithelial cells </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, <z:chebi fb="4" ids="53266">PPIs</z:chebi> have the ability to prevent <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule binding in malignant cells and suppress <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>This article reviews the role of <z:chebi fb="4" ids="53266">PPIs</z:chebi> in esophageal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> and their use as antitumor agents </plain></SENT>
</text></document>